Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuan Truong

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Leukemia & Lymphoma|February 3, 2022
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experienceMegan Melody, Sangeetha Gandhi, Hollie Saunders, et al.
European Journal of Haematology|March 3, 2021
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucelMegan Melody, Sangeetha Gandhi, Zaid Abdel Rahman, et al.
Cerebrovascular Diseases Extra|March 18, 2026
BRIDGING THROMBOLYSIS BEFORE ENDOVASCULAR THERAPY IMPROVES FUNCTIONAL OUTCOMES IN MEDIUM-LARGE CORE STROKE WITHIN 4.5 HOURS: A MULTICENTER PROPENSITY-MATCHED STUDYThang Huy Nguyen, Thien Quang Le, Trung Quoc Nguyen, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Leukemia & Lymphoma|February 3, 2022
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experienceMegan Melody, Sangeetha Gandhi, Hollie Saunders, et al.
European Journal of Haematology|March 3, 2021
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucelMegan Melody, Sangeetha Gandhi, Zaid Abdel Rahman, et al.
Cerebrovascular Diseases Extra|March 18, 2026
BRIDGING THROMBOLYSIS BEFORE ENDOVASCULAR THERAPY IMPROVES FUNCTIONAL OUTCOMES IN MEDIUM-LARGE CORE STROKE WITHIN 4.5 HOURS: A MULTICENTER PROPENSITY-MATCHED STUDYThang Huy Nguyen, Thien Quang Le, Trung Quoc Nguyen, et al.
Pageof 3